We are live on ! Find out more
IRMD icon

iRadimed

145 hedge funds and large institutions have $340M invested in iRadimed in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 37 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 37

40% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 15

14% more capital invested

Capital invested by funds: $300M → $340M (+$40.5M)

4% more funds holding

Funds holding: 139145 (+6)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.42% less ownership

Funds ownership: 53.89%53.47% (-0.42%)

Holders
145
Holders Change
+6
Holders Change %
+4.32%
% of All Funds
2.08%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
21
Increased
64
Reduced
37
Closed
15
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SFA
151
Sequoia Financial Advisors
Ohio
-$568K -12,918 Closed
LSV Asset Management
152
LSV Asset Management
Illinois
-$554K -12,600 Closed
Marshall Wace
153
Marshall Wace
United Kingdom
-$463K -10,531 Closed
YIH
154
Y-Intercept (HK)
Hong Kong
-$419K -9,535 Closed
Invesco
155
Invesco
Georgia
-$311K -7,081 Closed
XT
156
XTX Topco
Cayman Islands
-$265K -6,036 Closed
B
157
Bailard
California
-$202K -4,600 Closed
NC
158
nVerses Capital
Florida
-$17.6K -400 Closed
CPG
159
Cornerstone Planning Group
New Jersey
-$664 -15 Closed
IC
160
Innealta Capital
Texas
-$527 -12 Closed

IRMD Hedge Fund Activity: Q3 2024 in Review

145 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q3 2024, worth a combined $340M — up 14% from $300M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new IRMD positions and 15 closed out — a net gain of 6 holders — while 64 added to existing stakes and 37 trimmed.

The largest buyer was BlackRock, adding an estimated $5.6M. The largest seller was Bares Capital Management, exiting entirely with an estimated $12.5M sold.

  • 145 institutional investors held iRadimed (IRMD) as of Q3 2024, up from 139 in Q2 2024.
  • Funds reported $340M of iRadimed stock for Q3 2024, up 14% quarter-over-quarter.
  • 21 funds opened new iRadimed positions in Q3 2024 and 15 closed out, a net change of +6 holders.
  • The largest iRadimed buyer in Q3 2024 was BlackRock, an estimated $5.6M added.
  • The largest iRadimed seller in Q3 2024 was Bares Capital Management, an estimated $12.5M sold.

Based on aggregated 13F filings for Q3 2024.